Nami Surgical, based in Glasgow, Scotland, UK, has recently secured $4M in investment and grant funding. The company, which specializes in robotic-assisted surgery, was able to raise the funds with the help of Eos Advisory (Eos) and the Investment Fund for Scotland, with a $3.1M seed round. The goal is to use these funds to expand operations and focus on further developing the R&D sector of the company.
The team at Nami Surgical, led by CEO and Co-founder Nico Fenu and CTO and Co-founder Dr Rebecca Cleary, is dedicated to developing miniaturised ultrasonic medical devices for surgical applications.
Their innovative approach has led to the creation of a high-performance, miniaturised ultrasonic scalpel that has the potential to revolutionize robotic-assisted surgery. Nico Fenu highlighted the growing popularity of robot-assisted surgery across various medical fields and expressed excitement about the company's pilot programs with healthcare and medical device groups worldwide, including those in the United States.
Nami Surgical's success and groundbreaking developments in the field of robotic-assisted surgery are a testament to the dedication and expertise of its founders, Nico Fenu and Dr Rebecca Cleary. With the support of new investors, the company is poised to enter the commercialisation phase and bring its innovative solutions to a wider market. The expansion of operations and continued focus on R&D will further solidify Nami Surgical's position as a leader in the development of cutting-edge medical devices for surgical applications.
Click here for a full list of 6,908+ startup investors in the UK